Title: Current Recommendations for Managing Diabetes in Pregnancy Practical Ways to Achieve Targets in Diab
1Current Recommendations for Managing Diabetes in
PregnancyPractical Ways to Achieve Targets in
Diabetes CareBarbara Davis Center for Diabetes
and Childrens Diabetes Foundation at
DenverAugust 14, 2005
Director and Chief Scientific Officer Sansum
Diabetes Research Institute Santa Barbara,
California
2(No Transcript)
3(No Transcript)
4Pre-gestational Diabetes Complications Diagnosis
and Treatment
- Retinopathy Dilated retinal exam frequent
follow-up - Nephropathy 24 hour urine for Crcl, total
proteinuria, microalbuminuria - Hypertension BP lt120/80 mmHG (no ACE-I or
ARBs) - Hypothyroidism TSH lt 2.5 and FT4 gt1.0
- ASCVD Normal Stress Test with beat to beat
variability
5Preconception Care of Established
DiabetesPreventing Retinopathy Progression
- Rapid normalization of blood glucose during
pregnancy can trigger retinopathy progression - A preconception dilated eye exam should be
performed by an ophthalmologist - Retinal status should be stabilized prior to
conception - Reassess retinal status each trimester (more
frequently if retinopathy is present)
American Diabetes Association. Diabetes Care.
200427(suppl 1)S76-S78
6(No Transcript)
7(No Transcript)
8Diabetes in Early Pregnancy (DIEP) Trial
Prevalence of Major Fetal Complications
Control
Prevalence rate ()
Diabetes lt21 days postconception
10
9.0
P0.032
Diabetes gt21 days postconception
9
8
7
P0.027
6
4.9
5
4
2.1
3
2
1
0
Early-entry control
Early-entry diabetes
Late-entry diabetes
Mills JL et al. N Engl J Med. 1988318671-676
9Neonatal Outcomes Human Regular Insulin Use
During Pregnancy
10Neonatal Malformations Are Not Related to Type
of Insulin
15.8
Regular human insulin
16
Congenital malformation rate ()
Insulin lispro
14
12
10
7.9
P0.79
8
6.6
P0.16
6
3.8
4
2
0
GDM
Preexisting diabetes
N213
N97
Bhattacharyya A et al. Q J Med. 200194255-260
11Malformations Are Related to Glucose Not Type of
Insulin
Wyatt JW, Frias JL, Hoyme HE, Jovanovic L, et al.
Congenital anomaly rate in offspring of
pre-gestational diabetic women treated with
insulin lispro during pregnancy. Diabetic
Medicine 212001-2007, 2004.
12A. Standardized Maximum Glycosylated Protein
B. Standardized Maximum Fructosamine
IDDM Pregnancies
Nondiabetic Pregnancies
Jovanovic L et al. In Press, Diabetes Care 2005
13Prevalence of Diabetes in Pregnancyin the United
States of America
- 4.5 millions births per year
- 240,000 T2DM 6,000 T1DM pregnancies 135,000
GDM
Diabetes 8
Non-diabetes 92
American Diabetes Association. Diabetes Care.
199821(Suppl. 2).
14Enrollment and Outcomes
Crowther, C. et al. N Engl J Med
20053522477-2486
15Primary Clinical Outcomes among the Infants and
Their Mothers
Crowther, C. et al. N Engl J Med
20053522477-2486
16Secondary Outcomes among the Infants
Crowther, C. et al. N Engl J Med
20053522477-2486
17(No Transcript)
18(No Transcript)
19Fetal Hyperglycemia
Stimulates fetal pancreas
Insulin
Placenta
Fetal Hyperinsulinemia
IgG-antibody-bound Insulin
Mother
Fetus
20 Macrosomia
21Magnetic Resonance Image of Pregnancy
Complicated by Diabetes
Normoglycmia
Hyperglycmia
Jovanovic L et al. Am J Perinatol. 199310432-437
22(No Transcript)
2338 Weeks Gestation
28 Weeks Gestation
120
110
5.6 mmol/L
100
90
Blood glucose (mg/dL)
80
70
3.3 mmol /L
60
50
40
8 AM
9 AM
10 AM
12 PM
1 PM
2 PM
4 PM
6 PM
8 PM
9 PM
10 PM
12 AM
2 AM
4 AM
6 AM
24Relationship Between Number of Blood Glucose
Determinations and A1C
25"Hyperglycemic Peaks" Risk of Macrosomia
60 50 40 30 20 10 0
Risk of Macrosomia
80
90
100
110
120
130
140
150
160
170
180
Blood Glucose 1 hour after beginning the meal
(mg/dL)
Jovanovic L et al. Maternal postprandial blood
glucose levels and infant birth weight The
Diabetes in Early Pregnancy Study. Am J Obstet
Gynecol. 1991164103.
26The U-Shaped CurveBirth Weight vs. Risk of Type
2 Diabetes
25
20
15
Percent
10
5
0
1500
2500
3500
4500
Birth weight (grams)
27What is the Optimal Diet for Pregnant Diabetic
Women to Prevent Neonatal Macrosomia?
28(No Transcript)
29(No Transcript)
30(No Transcript)
31(No Transcript)
32MiniMed Continuous Glucose Monitoring System
(CGMS)
33Glucose Sensor Profile Unrecognized "Peaks"
11.1 mmol /L
34Total Amount of Time Per Day Hyperglycemic (In
Hours)
35Interstitial Fluid Glucose Sensors
GlucoWatch
DexCom
36Indications for Insulin Therapy in GDM
- Fasting blood glucose concentration gt 90 mg/dl
(5.0 mmol/L) - and/or
- 1-hour postprandial blood concentration gt 120
mg/dl (6.7 mmol/L)
37Physiological Serum Insulin Secretion Profile
75
Breakfast
Lunch
Dinner
50
Plasma Insulin µU/ml)
25
400
800
1200
1600
2000
2400
400
800
Time
38Insulin Antibodies Relate to Diabetes Duration
and Do Not Impact Glucose Control
8000
Insulin antibody titer IgG (?U/mL)
r0.73
6000
4000
2000
1000
800
600
400
200
100
5
0
10
15
20
25
Years of treatment with conventional insulin
Jovanovic LG et al. Diabetes Care. 1984768-71
39Postprandial Hyperglycemia
140 120 100 80 60 40 20
Lispro insulin Human regular insulin
Plasma glucose (mg/dL)
0 50 100 150
200
Time (min)
40Maternal Hyperglycemia - 1Hour Postprandial
41Change in HbA1c
Lispro insulin Human regular insulin
5.5 5.4 5.3 5.2 5.1 5.0 4.0
Baseline Endpoint
42Insulin Antibody Findings
43Postprandial Glycemic Control inGDM NovoLog vs
Regular Insulin
Study group 15 insulin-requiring women with
GDM meal testing before initiation of
basal/bolus therapy
Insulin (?U/mL)
C-peptide (ng/dL)
Glucose (mg/dL)
100
8
7
80
6
5
60
4
40
3
2
20
1
0
0
-60
0
60
120
180
240
-60
0
60
120
180
240
Jovanovic et al. Diabetes 51 (suppl 2) abstrac
1784-2002
Time (minutes)
44Insulin Treatment and Antibodies
45Insulin PreparationsAdvantages and Disadvantages
During Pregnancy
Advantages
Disadvantages
- Delayed and prolonged
- action profile does not
- match mealtime needs
Regularhuman insulin Lispro Aspart Glulisine N
PH Glargine Detemir
- Action profile matches
- well with mealtime needs
- Limited objective data
- verifying safety in pregnancy
- Long experience verifies
- safety in pregnancy
- Peak action profile
- requires multiple injections
- for smooth 24-hour effect
- Flatter 24-hour profile
- allows fewer injections
- No objective data verifying
- safety in pregnancy
46Evidence that Drug Does Crosses The Placenta
- Sufonylureas Yes No None
- Second generation x x
- Bigunides
- Metformin x
- Meglitinides
- Repaglinide and x
- Netaglimide x
- Alpha glucosidase inhibitors
- Acarbose x
- Thiazolidienediones X
47 Insulin Requirements for Pregnant Diabetic Women
48Six Injections/Daily Insulin AlgorithmNPH Three
Times Premeal Aspart or Lispro
Plasmainsulin
2400
400
2400
1600
2000
1200
800
NPH
NPH
NPH
NPH
Time
49Bolus and Variable Basal RateCSII Program
Infusion rate
3 U
2 U
1 U
400
1600
2000
2400
1200
800
2400
Time
50Neonatal Hypoglycemia Is Inversely Related to
Maternal Hyperglycemia at Delivery
Glucose(mg/dL)
250
Type 1 DM
200
Type 2 DM
Gestational DM
150
100
50
0
Maternal Glucose
Neonatal Glucose
Adapted from Jovanovic L et al. Am J Med.
198375607-612
51Labor and Delivery
- Labor is exercise
- Exercise requires glucose substrate
- Exercise obviates the insulin requirement
- Frequent fetal monitoring, blood glucose testing
hourly, maintenance of blood glucose less than
90 mg/dl - JOVANOVIC L. Glucose and insulin requirements
during labor and delivery the case for
normoglycemia in pregnancies complicated by
diabetes. Endocrine Practice 1040-45, 2004.
52Insulin Protocol for Labor and Delivery in
Type 1 Diabetic Women on Insulin Pumps Basal
insulin infusion rate 1/2 half on MDI
Discontinue the NPH insulin GLUCOSE ADJUSTMEN
TSlt70 mg/dL Dl0NS for10 to 15 minutes rate 100
ml/hr) 71-100 mg/dL D5NS/l00 ml/hr101-120
mg/dL NS/l00 ml/hr______________________________
___________________gt 121 mg/dL NS plus Regular
insulin IV or bolus analog sc/hr As Percent of
Big I121-140 mg/dL NS/l00 ml/hr Plus 3
Big I gt141 mg/dL NS/l00 ml/hr Plus 6 Big
I ____________________________________________
______ Big I The Total Daily Insulin
Requirement Note at Term it is 1.0 units per
kilogram per day. Thus 3 of this dose would be
3 units in a 100 kilogram woman at term
53Thank You